Maxcyte (MXCT) Return on Assets (2021 - 2025)

Maxcyte (MXCT) has disclosed Return on Assets for 5 consecutive years, with 0.21% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 7.0% to 0.21% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.21%, a 7.0% decrease, with the full-year FY2024 number at 0.16%, down 3.0% from a year prior.
  • Return on Assets was 0.21% for Q3 2025 at Maxcyte, down from 0.2% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.06% in Q1 2022 to a low of 0.21% in Q3 2025.
  • A 5-year average of 0.12% and a median of 0.14% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: changed 0bps in 2024, then fell -7bps in 2025.
  • Maxcyte's Return on Assets stood at 0.07% in 2021, then decreased by -21bps to 0.08% in 2022, then tumbled by -72bps to 0.14% in 2023, then decreased by -19bps to 0.17% in 2024, then fell by -25bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Return on Assets are 0.21% (Q3 2025), 0.2% (Q2 2025), and 0.18% (Q1 2025).